Cloniprazepam
Cloniprazepam is a benzodiazepine derivative and a psychoactive drug that has sedative, hypnotic, anxiolytic, and muscle relaxant properties. It is a chlorinated derivative of nitrazepam, a well-known benzodiazepine drug used for the treatment of insomnia and anxiety disorders. Cloniprazepam itself is not approved for medical use in many countries and is often encountered on the designer drug market where it is used for recreational purposes and self-medication.
Chemistry[edit | edit source]
Cloniprazepam, chemically known as 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one, is part of the benzodiazepine class of compounds. It has a core benzodiazepine structure with a nitro group (NO2) at the 7 position and a chlorine atom at the 2' position on the phenyl ring. This structural modification contributes to its pharmacological properties, distinguishing it from its parent compound, nitrazepam.
Pharmacology[edit | edit source]
As with other benzodiazepines, cloniprazepam acts on the GABAA receptor in the brain. It enhances the effect of the neurotransmitter GABA (gamma-aminobutyric acid), which is the primary inhibitory neurotransmitter in the brain. The activation of GABAA receptors opens chloride channels leading to an influx of chloride ions into the neuron, making it more resistant to depolarization. This mechanism underlies the sedative, anxiolytic, muscle relaxant, and anticonvulsant effects of benzodiazepines.
Effects[edit | edit source]
The effects of cloniprazepam can include sedation, relaxation, reduction of anxiety, and suppression of seizures. However, its use is also associated with risks such as dependence, tolerance, and withdrawal symptoms upon cessation. The recreational use of cloniprazepam and other designer benzodiazepines can lead to adverse effects, including severe sedation, respiratory depression, amnesia, and impaired motor functions.
Legal Status[edit | edit source]
The legal status of cloniprazepam varies by country, but it is often listed as a controlled substance due to its potential for abuse, dependence, and harm. In jurisdictions where it is controlled, possession, distribution, and manufacture of cloniprazepam without a license are prohibited.
See Also[edit | edit source]
- Benzodiazepine
- Nitrazepam
- Designer drug
- [[GABAA receptor]]
Cloniprazepam Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD